Constitution Capital Access Fund, LLC

 

 

Consolidated Schedule of Investments

June 30, 2026 (Unaudited)

 

                                                                                                                                                                                                        
Investments - 111.9%⁷   Sector   Investment Type   Acquisition
Date
  Shares   Cost   Fair Value  
Direct Investments - 73.7%¹ʼ²                              
Direct Credit - 0.2%                              
North America - 0.2%                              
Donut Acquisition Co.9,10
($49,091 principal amount, 8.42% Cash (CME Term SOFR 3M+4.75%, 1.00% Floor), 5/30/2031)
  Consumer Staples   Subordinated debt   5/30/2025       $ 49,091   $ 49,586  
Gula Buyer, Inc.9,10
($244,500 principal amount, 8.13% Cash (CME Term SOFR 1M+4.50%, 0.75% Floor), 10/25/2031)
  Consumer Discretionary   Subordinated debt   10/25/2024         244,500     244,500  
PracticeTek Midco, LLC9
($1,468,068 principal amount, 14% PIK, 8/30/2030)
  Financial Technology   Subordinated debt   8/30/2023         1,468,068     1,468,068  
Total Direct Credit                     1,761,659     1,762,154  
                               
Direct Equity - 73.5%                              
Asia - Pacific - 2.9%                              
SLP Rainbow Co-Invest, L.P.*   Consumer Staples   Limited partnership interest   10/1/2022         11,141,955     11,965,228  
SLP Redwood Co-Invest, L.P.*   Communication Services   Limited partnership interest   10/1/2022         8,598,548     11,143,732  
Total Asia - Pacific                     19,740,503     23,108,960  
                               
Europe - 7.8%                              
AHP Horsepower Co-Invest L.P.*   Health Care   Limited partnership interest   12/19/2025   5,894     5,954,006     8,212,063  
BW CDMO Co-Invest, L.P.*   Health Care   Limited partnership interest   11/4/2024         10,358,553     6,277,069  
CVC Capital Partners Pachelbel (A) SCSp*3,8   Education Services   Limited partnership interest   7/8/2024         2,238,381     3,376,128  
Kirk Beauty Co-Investment Limited Partnership*8   Consumer Discretionary   Limited partnership interest   10/1/2022         6,888,562     2,220,039  
LEP CP Co-Invest L.P.*3,8   Industrials   Limited partnership interest   3/27/2025         6,639,912     6,763,607  
Mayfair Olympic Holdco Limited*8,9   Utilities   Ordinary Shares   10/1/2022   1,243,556     7,914,290     5,264,239  
Neptune Co-Investment, L.P.*3   Energy   Limited partnership interest   10/1/2022         9,815,968     891,101  
SLP Jewel Co-Invest, L.P.*   Consumer Discretionary   Limited partnership interest   10/1/2022         5,883,679     7,861,327  
SLP Mistral Co-Invest, L.P.*   Financials   Limited partnership interest   10/1/2022         14,200,580     18,184,160  
SLP Zephyr Investors, L.P.*   Communication Services   Limited partnership interest   10/1/2022         7,836,121     3,578,075  
Total Europe                     77,730,052     62,627,808  

 

See accompanying notes to the Consolidated Schedule of Investments

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

                                                                                                                                                                                                        
Investments - 111.9%⁷  Sector  Investment Type  Acquisition
Date
  Shares  Cost Fair Value  
Direct Investments (Continued)                        
Direct Equity (Continued)                            
North America - 62.8%                     
ABCL Equity Investors, L.P.*  Professional Services  Limited partnership interest  8/12/2025     $5,009,332 $ 4,998,981  
ACP Canopy Co-Invest LLC*  Health Care  Limited liability company interest  11/1/2022  20,082   20,081,967    26,073,908  
ACP Ukulele Co-Invest LP  Health Care  Common Units  3/4/2024  25,671   3,888,549    7,509,790  
Ares Constellation Private Equity Fund LP*3  Industrials  Limited partnership interest  2/25/2026      1,630,182    2,103,123  
Ares EPIC Co-Invest Delaware Feeder, L.P.*3  Energy  Limited partnership interest  10/1/2022      -  559,801  
Ares EPIC Co-Invest II L.P.*3  Energy  Limited partnership interest  10/1/2022      -  95,500  
Avista Healthcare Partners
CV II, L.P.3
  Industrials  Limited partnership interest  7/1/2025      2,031,981  2,259,318  
BP ACE CV, L.P.*3  Information Technology  Limited partnership interest  12/12/2025      7,655,815  10,612,310  
Brightwood MOI, LLC*9  Consumer Discretionary  Limited liability company interest  1/5/2026      5,000,000  5,000,000  
Carlyle Sabre Coinvestment, L.P.*  Industrials  Limited partnership interest  10/1/2022      4,325,654  10,234,216  
CC AEC Co-Invest L.P.*  Health Care  Limited partnership interest  10/1/2022  5,948   5,957,934  3,269,007  
CCP AMP Holdings, LLC*  Health Care  Limited liability company interest  11/28/2025      10,038,961    21,172,033  
Centeotl Co-Invest B, L.P.*3  Consumer Staples  Limited partnership interest  5/15/2023      5,160,290  5,015,214  
COP Accounting Investment, LLC*9  Industrials  Class A Units  10/31/2025  5,000,000   5,017,316  5,000,000  
COP Exterminators Investment, LLC *9  Consumer Staples  Limited liability company interest  7/28/2023  8,035,714   9,000,000  11,640,062  
Donut Topco LLC*9  Consumer Staples  Class A Units  5/30/2025  10,000   10,000,000  10,000,000  
Ergotron Investments, LLC*9  Industrials  Common Units  10/1/2022  50,000   5,000,000  5,280,254  
Gula Co-Invest II, L.P.*3  Consumer Discretionary  Common Units  10/23/2024  5,000   5,025,000  7,068,543  
Hermod Co-Invest, LP*3  Consumer Discretionary  Common Units  10/15/2024  5,000,000   5,154,248  9,514,437  
Hildred Capital ACP-A, LP*3  Health Care  Limited partnership interest  11/12/2025      5,849,288  8,789,038  
Hildred Capital Co-Invest-REBA, LP*3  Health Care  Limited partnership interest  1/15/2025      14,595,795  21,823,325  
Iaso Fund, L.P.*3  Health Care  Limited partnership interest  12/12/2025      9,954,380  10,560,845  
Ishtar Co-Invest-B LP*3  Consumer Staples  Limited partnership interest  11/4/2022      5,851,409  47,984,000  
KLC Fund 0325-CI LP*3  Health Care  Limited partnership interest  5/9/2025      4,098,537  4,000,000  
LC Ahab Aggregator, LP*  Consumer Discretionary  Limited partnership interest  7/31/2024  5,000   3,104,978  9,002,907  
LC10 Flash Non-US Aggregator, LP  Consumer Discretionary  Class A Units  2/6/2026  5,000   4,427,607  7,989,768  
LCG5 Candlelight, L.P.*  Communication Services  Limited partnership interest  2/24/2025  1,000,000   10,322,863  22,000,278  
LCMM Revolution Aggregator, L.P.*  Consumer Discretionary  Class A Units  7/14/2025  5,000   5,016,787  7,934,265  
LGP Sage CVT Coinvest LP*3  Industrials  Limited partnership interest  3/10/2026      5,735,415  7,189,614  
LGP Sage PC Coinvest LP3  Industrials  Limited partnership interest  5/1/2025      7,745,717  11,230,791  
LH Equity Investors, L.P.*  Industrials  Limited partnership interest  9/3/2025      9,633,007    13,591,792  

 

See accompanying notes to the Consolidated Schedule of Investments

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

                                                                                                                                                                                                        
Investments - 111.9%⁷  Sector  Investment Type  Acquisition
Date
  Shares  Cost Fair Value  
Direct Investments (Continued)                            
Direct Equity (Continued)                            
North America (Continued)                    
MiddleGround Edge
Co-Invest Partners, L.P.*9
  Industrials  Limited partnership interest  6/30/2026  7,692,308  $10,000,000 $ 15,221,819  
MyTown Health Partners Parent, LP*3,9  Health Care  Limited partnership interest  7/17/2024  5,458,864   6,075,796  7,189,702  
NBPT Aggregator, LLC*3,9  Health Care  Preferred Units  2/28/2025  8,000   8,023,333  10,493,972  
NE Parent Holdings, LLC*9  Communication Services  Common Units  8/29/2025  65,313   4,441,028  6,894,437  
NE Parent Holdings, LLC*9  Communication Services  Preferred Units  8/29/2025  5,050   3,515,098  4,847,039  
Oshun Co-Invest-B LP*3  Consumer Staples  Limited partnership interest  11/4/2022      3,208,978  2,857,550  
PT Co-Invest II, L.P.*3  Financial Technology  Limited partnership interest  8/28/2023      10,096,741  11,729,038  
RCP Monte Nido
Co-Investment Fund, L.P.*
  Health Care  Limited partnership interest  4/10/2023      6,256,226  3,693,165  
RCP MQ Co-Investment Fund, L.P.*  Health Care  Limited partnership interest  12/2/2024      3,453,460  6,595,442  
RCP Ocean Co-Investment Fund, L.P.*  Information Technology  Limited partnership interest  4/23/2025      6,171,604  6,608,182  
s20 SPV VIII, a Series of CGF2021 LLC*  Financials  Limited partnership interest  9/30/2025      10,550,794    23,169,567  
s20 SPV X, a Series of CGF2021 LLC*  Financials  Limited partnership interest  10/15/2025      5,594,970  11,840,000  
SLP Blue Co-Invest, L.P.  Information Technology  Limited partnership interest  10/1/2022      8,733,044  8,002,032  
SLP West Holdings Co-Invest II, L.P.5  Communication Services  Limited partnership interest  10/1/2022      9,344  640,027  
Thorium AppDirect Co-Invest, LLC*  Information Technology  Limited liability company interest  9/30/2024  10,000,000   10,806,012    27,900,908  
TPG VII Renown Co-Invest II, L.P.*  Consumer Discretionary  Limited partnership interest  10/1/2022      5,098,713  37,623  
VAL CoInvest, LP*3  Industrials  Limited partnership interest  1/6/2026      5,049,554  7,492,500  
VCP Roland Co-Invest Aggregator, L.P.*  Consumer Staples  Limited partnership interest  10/21/2024  5,000   5,094,389  4,995,474  
VCP Tech24 Co-Invest Aggregator, L.P.*  Business Services  Limited partnership interest  5/15/2024  5,000   5,669,741  4,666,139  
WE Select Fund 1, L.P.*3  Health Care  Limited partnership interest  2/5/2025      4,561,346  5,698,815  
WPP Fairway Aggregator B, L.P.*9  Consumer Staples  Class A Preferred Units  10/1/2022  13,053   13,053,292  13,061,759  
WPP Fairway Aggregator B, L.P.*9  Consumer Staples  Class B Common Units  10/1/2022  13,053   87,364  -  
Total North America               331,863,839    503,138,310  
Total Direct Equity               429,334,394    588,875,078  
Total Direct Investments - 73.7%               431,096,053    590,637,232  

 

See accompanying notes to the Consolidated Schedule of Investments

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

                                                                                                                                                                                                        
Investments - 111.9%⁷  Sector  Investment Type  Acquisition
Date
 Shares  Cost  Fair Value  
Investment Funds - 36.6%¹ʼ²                       
Asia - Pacific - 1.9%                                     
BPEA Private Equity Fund VI, L.P.23     Limited partnership interest  10/1/2022     $10,242,680  $1,585,806  
BPEA Private Equity Fund VII, SCSp3     Limited partnership interest  10/1/2022      19,009,158   13,861,840  
Total Asia - Pacific               29,251,838   15,447,646  
                       
Europe - 6.8%                      
CVC Capital Partners VI (D) S.L.P.3,8     Limited partnership interest  10/1/2022      13,589,985   7,085,877  
CVC Capital Partners VII (A) L.P.3,8     Limited partnership interest  10/1/2022      16,223,840   14,232,477  
EQT IX (No.1) EUR SCSp3,8     Limited partnership interest  10/1/2022      12,136,291   13,316,312  
EQT VII (No.1) Limited Partnership*3,8     Limited partnership interest  10/1/2022      7,672,322   3,882,413  
EQT VIII (No.1) SCSp3,8     Limited partnership interest  10/1/2022      17,050,800   7,582,524  
Sixth Cinven Fund (No. 2) Limited Partnership3,8     Limited partnership interest  10/1/2022      17,560,974   8,494,259  
Total Europe               84,234,212   54,593,862  
                       
North America - 27.9%                      
Ares Corporate Opportunities Fund V, L.P.*3     Limited partnership interest  10/1/2022      12,697,020   8,630,918  
Ares Corporate Opportunities Fund VI Parallel (TE), L.P.3     Limited partnership interest  10/1/2022      19,466,380   28,335,474  
Ares Energy Opportunities Fund B, L.P.3     Limited partnership interest  10/1/2022      3,175,675   1,925,433  
Avista Healthcare Partners
(Offshore) II, L.P.3
     Limited partnership interest  3/31/2025      9,715,083   11,738,294  
Bansk Fund I-B, L.P.*3     Limited partnership interest  9/13/2023      2,497,899   5,252,547  
Bansk Fund II-B, L.P.*3     Limited partnership interest  1/30/2026      2,559,619   2,588,005  
Carlyle International Energy Partners II S.C.Sp.3     Limited partnership interest  10/1/2022      13,222,073   12,388,190  
Carlyle Partners VI, L.P.3,4     Limited partnership interest  10/1/2022      3,835,031   1,052,409  
Carlyle Partners VII, L.P.3     Limited partnership interest  10/1/2022      7,604,385   7,308,191  
Catterton Partners VII, L.P.*3     Limited partnership interest  10/1/2022      17,152,531   9,743,379  
Gridiron Capital (Parallel) Fund V, L.P.*3     Limited partnership interest  11/27/2023      4,459,597   5,271,921  
Insignia Capital Partners, L.P.3,4     Limited partnership interest  10/1/2022      28,787,806   8,117,791  
Investcorp Strategic Capital Partners II-B, L.P.*3     Limited partnership interest  3/27/2026      1,320,376   1,252,759  
L Catterton Growth VI, L.P.*3     Limited partnership interest  1/30/2026      36,501   248,835  
Lightyear Fund III, L.P.4     Limited partnership interest  10/1/2022      -   21,565  
Revelstoke Capital Partners Fund III, L.P.3     Limited partnership interest  8/22/2023      4,198,483   5,125,503  
Riverstone Global Energy and Power Fund VI, L.P.3     Limited partnership interest  10/1/2022      3,582,032   924,362  
Riverstone Non-ECI Partners, L.P.3     Limited partnership interest  10/1/2022      8,494,738   59,609  
Sage Equity Investors Side, L.P.*3     Limited partnership interest  2/10/2026      1,113,471   1,641,466  
Silver Lake Partners IV, L.P.3,4     Limited partnership interest  10/1/2022      12,647,292   14,633,782  
Silver Lake Partners V, L.P.3,4     Limited partnership interest  10/1/2022      18,141,133   18,712,037  

 

See accompanying notes to the Consolidated Schedule of Investments

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

                                                                                                                                                                                                        
Investments - 111.9%⁷  Sector  Investment Type  Acquisition
Date
 Shares  Cost  Fair Value  
Investment Funds (Continued)                       
North America (Continued)                       
SK Capital Partners III, L.P.*3     Limited partnership interest  10/1/2022     $20,659,748  $4,113,766  
SL SPV-2, L.P.     Limited partnership interest  10/1/2022      5,097,745   13,671,531  
SunTx Capital Partners II, L.P.*     Limited partnership interest  10/1/2022      6,048,777   26,146,840  
TPG HealthCare Partners, L.P.*3     Limited partnership interest  10/1/2022      5,522,762   6,220,851  
TPG Partners VI, L.P.*3     Limited partnership interest  10/1/2022      2,668,398   643,765  
TPG Partners VIII, L.P.3     Limited partnership interest  10/1/2022      19,043,555   18,917,672  
Webster Equity Partners VI, L.P.*3     Limited partnership interest  2/3/2026      1,508,486   1,443,578  
WestView Capital Partners III, L.P.*3     Limited partnership interest  10/1/2022      8,420,990   1,547,818  
Wind Point Partners VII-B, L.P.*3     Limited partnership interest  10/1/2022      1,762,977   26,780  
Wind Point Partners X-B, L.P.*3     Limited partnership interest  4/5/2024      4,585,565   5,607,429  
Total North America               250,026,128   223,312,500  
Total Investment Funds - 36.6%               363,512,178   293,354,008  
                       
Short-Term Investments - 1.6%                      
North America - 1.6%                      
Fidelity Institutional Government Portfolio - Class I, 3.53%6           13,012,587   13,012,587   13,012,587  
Total Short-Term Investments - 1.6%               13,012,587   13,012,587  
                       
Total Investments - 111.9%               807,620,818   897,003,827  
Net Other Assets (Liabilities) - (11.9%)                   (95,228,724)  
Total Net Assets - 100.0%                  $ 801,775,103  

 

Legend

 

SOFR- Secured Overnight Financing Rate
CME Term SOFR 1M - Chicago Mercantile Exchange forward looking measure of SOFR for one month: 3.65%, as of June, 2026. Actual reference rates may vary based on the reset date of the security.
CME Term SOFR 3M - Chicago Mercantile Exchange forward looking measure of SOFR for three months: 3.73%, as of June 30, 2026. Actual reference rates may vary based on the reset date of the security.

 

*Investment is non-income producing.
1Direct Investments and Investment Funds are generally issued in private placement transactions and as such are generally restricted as to resale. Each investment may have been acquired on various dates and for different amounts. The acquisition date is shown in the Consolidated Schedule of Investments. Total fair value of restricted investments as of June 30, 2026 was $883,991,240, or 110.3% of net assets. Total cost of restricted investments as of June 30, 2026 was $794,608,231.
2Direct Investments and Investment Funds do not allow redemptions or withdrawals except at discretion of their general partner, manager, or adviser.
3Investment has been committed to but has not been fully funded by the Fund.
4All or a portion of this security is held through a consolidated Subsidiary, CC PMF Splitter Partnership.
5All or a portion of this security is held through a consolidated Subsidiary, CC PMF Blocker, LLC.
6The rate is the annualized seven-day yield as of June 30, 2026.
7Investments are held through CC PMF Holdings, LLC, a consolidated Subsidiary, unless otherwise denoted.
8Foreign security denominated in U.S. Dollars.
9The fair value of the investment was determined using significant unobservable inputs.
10Variable rate security. Rate shown is the rate in effect as of June 30, 2026.

 

See accompanying notes to the Consolidated Schedule of Investments

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Notes To Consolidated Schedule of Investments

June 30, 2026 (Unaudited)

 

Note 1 - Valuation of Investments

 

The Fund invests, under normal circumstances, in a broad portfolio of private assets and values them at fair value in accordance with the provisions of ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). The Fund’s investments include a broad portfolio of high-quality investments in private assets that the Adviser believes provide attractive risk-adjusted return potential. Private asset investments include Direct Investments (except for publicly listed private equity investments), Secondary Investments, and Primary Investments, each as defined below (collectively, “Private Assets”). Private Assets include (i) direct investments in the equity or debt of operating companies and investments in co-investment vehicles managed or sponsored by a third-party investment manager (“Sponsor”) to access positions in the equity or debt of a single operating company (“Direct Equity Investments” or “Direct Credit Investments,” respectively, and together, “Direct Investments”); (ii) secondary purchases (i.e. purchases of existing interests that are acquired on the private secondary market) (“Secondary Investments”) of closed-end private funds (“Portfolio Funds”) managed by Sponsors; and (iii) primary investments in Portfolio Funds (i.e. commitments to new private equity or other private funds, which are sourced and diligenced by the Adviser (“Primary Investments”). The Fund’s investments may also include (iv) direct or secondary purchases of liquid credit instruments; (v) other liquid investments, such as investments in publicly listed companies that pursue the business of private equity investing, including private equity investments that are publicly traded, listed funds of funds, alternative asset managers, holding companies, investment trusts, closed-end funds, financial institutions and other vehicles whose primary purpose is to invest in privately held companies (“Other Liquid Investments”); and (vi) short-term investments, which generally are cash equivalents that represent investments in high quality money market instruments and/or money market mutual funds (together, “Short-term Investments”). The investments covered by romanettes (iv) through (vi) are not Private Assets.

 

The Adviser has been designated by the Board as the valuation designee for the Fund pursuant to Rule 2a-5 of the Investment Company Act (“Rule 2a-5”) to perform fair value determinations and has approved valuation procedures for the Fund. Rule 2a-5 establishes requirements for determining fair value in good faith for purposes of the Investment Company Act, defines when market quotations are “readily available” for purposes of the Investment Company Act and the threshold for determining whether a fund must fair value a security.

 

Where available, the Fund uses the net asset value (“NAV”) reported by Sponsors and Investment Fund Managers as a practical expedient in determining their fair values as of a valuation date for the Fund, in accordance with ASC 820. If the most recent NAV is reported as of a date which does not align with the valuation date for the Fund, the Adviser assesses whether an adjustment to the most recently reported NAV is justified in accordance with the Fund’s valuation procedures. In making this assessment, the Adviser considers, among other things, information provided by the Sponsors and Investment Fund Managers, including quarterly unaudited financial statements and cash flow activity observed during the period between the most recently reported NAV date and the valuation date for the Fund. The Adviser will also review the appropriateness of the adjustment to the most recently reported NAV based on any new information or changes in assumptions regarding the security, reliable public information, actual trade prices or other information that becomes available subsequent to the most recently reported NAV.

 

If an investment does not meet the qualifications of an investment company under ASC 946, the Adviser may make a fair value determination by utilizing information provided by the Sponsor or Investment Fund Manager, including quarterly unaudited financial statements, financial forecasts, and cash flow activity observed during the valuation period. The Adviser may also utilize the cost of the investment, or income and market-based valuation techniques acceptable under ASC 820, which may incorporate unobservable inputs. These techniques may include references to market multiples, valuations for comparable companies, public market or private transactions, subsequent developments concerning the companies to which the securities relate, results of operations, financial condition, cash flows, and projections of such companies provided to the Adviser and such other factors as the Adviser may deem relevant. Depending on the circumstances, company multiples will not always be comparable due to the size of the related companies or associated transactions being used as comparable data in valuation.

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Notes To Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

As part of its valuation process, the Adviser also performs backtesting of its fair value estimates against information that is subsequently received from Sponsors and Investment Fund Managers, where available. The Adviser has established an internal valuation committee consisting of senior members of the organization to review and approve valuations related to the Direct Investments and Investment Funds as of each valuation date.

 

The Board oversees the Adviser in its role as valuation designee and receives quarterly reports from the Adviser regarding the valuation of the Direct Investments and Investment Funds, including information regarding fair value determinations, valuation methodologies, and any changes to valuation policies or procedures.

 

For investments that are publicly traded and have market quotations readily available on one or more of the U.S. national securities exchanges, the Nasdaq Stock Market or any foreign stock exchange, valuations will be based on their respective market price and may be further adjusted for potential restrictions on the transfer or sale of such securities.

 

Note 2 – Fair Value Measurements

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price), or in the absence of a principal market, the most advantageous market for the asset, and establishes a fair value hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Adviser. Unobservable inputs reflect the Adviser’s assumption about the inputs market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. The types of financial instruments included in Level 1 are listed unrestricted securities, equities and listed derivatives, if any, listed in active markets.

 

Level 2 – Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly in active markets as of the reporting date, and fair value that is determined using models or other valuation methodologies. Financial instruments in this category generally include corporate bonds and loans, less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, over-the-counter derivatives where fair value is based on observable inputs and interests in Private Assets whose fair value is predominantly attributable to investments in Level 1 type securities. A significant adjustment to a Level 2 input could result in the Level 2 measurement becoming a Level 3 measurement.

 

Level 3 – Inputs that are unobservable for the asset or liability and that include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information in the circumstances and may require significant management judgment or estimation. Financial instruments in this category generally include equity and debt positions in private companies, and non-redeemable investments in alternative investment funds, non-investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives, if any, where the fair value is based on unobservable inputs.

 

ASC 820 also permits a reporting entity to measure the fair value of an asset that does not have a readily determinable fair value based on the reported NAV per share, or its equivalent, as a practical expedient for its fair value. Accordingly, the Fund may utilize the NAV per share as reported by certain Sponsors and Investment Fund Managers as of a valuation date as a practical expedient for its fair value. If the NAV reported by certain Sponsors and Investment Fund Managers is not as of the same date as the valuation date, the Fund is permitted under ASC 820 to estimate the fair value of those Private Assets by adjusting the most recently reported NAV as a practical expedient for fair value.

 

 

 

 

Constitution Capital Access Fund, LLC

 

 

Notes To Consolidated Schedule of Investments (Continued)

June 30, 2026 (Unaudited)

 

The Fund’s investments that are measured at fair value using NAV per share (or its equivalent) as a practical expedient are generally not redeemable during the life of each Direct Investment and Investment Fund. These investments may be subject to lock-up provisions, investment periods, and other restrictions on transfer, and the Fund may not be able to sell such interests in Direct Investments and Investment Funds in secondary transactions at amounts approximating NAV.

 

Due to the inherent uncertainty of estimates, fair value determinations based on estimates may materially differ from the values that would have been used had a ready market for the securities existed.

 

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

 

The following table is a summary of information about the levels within the fair value hierarchy at which the Fund’s investments are measured as of June 30, 2026:

 

   Level 1   Level 2   Level 3   NAV as a
Practical
Expedient(1)
   Total 
Investments                    
Direct Investments  $   $2,220,039   $101,655,437   $486,761,756   $590,637,232 
Investment Funds               293,354,008    293,354,008 
Short-Term Investments   13,012,587                13,012,587 
Total Investments  $13,012,587   $2,220,039   $101,655,437   $780,115,764   $897,003,827 

 

(1)Direct Investments and Investment Funds that are measured at fair value using NAV (or its equivalent) as a practical expedient are not required to be categorized in the fair value hierarchy. The fair values presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Schedule of Investments.